153 related articles for article (PubMed ID: 16810312)
1. DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.
Taylor NP; Zighelboim I; Huettner PC; Powell MA; Gibb RK; Rader JS; Mutch DG; Edmonston TB; Goodfellow PJ
Mod Pathol; 2006 Oct; 19(10):1333-8. PubMed ID: 16810312
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas.
Hoang LN; Ali RH; Lau S; Gilks CB; Lee CH
Int J Gynecol Pathol; 2014 Sep; 33(5):483-91. PubMed ID: 25083964
[TBL] [Abstract][Full Text] [Related]
3. Defective DNA mismatch repair and XRCC2 mutation in uterine carcinosarcomas.
Taylor NP; Gibb RK; Powell MA; Mutch DG; Huettner PC; Goodfellow PJ
Gynecol Oncol; 2006 Jan; 100(1):107-10. PubMed ID: 16169065
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability in uterine sarcomas.
Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
[TBL] [Abstract][Full Text] [Related]
5. Warthin tumors do not have microsatellite instability and express normal DNA mismatch repair proteins.
Hunt JL
Arch Pathol Lab Med; 2006 Jan; 130(1):52-6. PubMed ID: 16390238
[TBL] [Abstract][Full Text] [Related]
6. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R
J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473
[TBL] [Abstract][Full Text] [Related]
7. Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Multi-institution Retrospective Review.
Jenkins TM; Hanley KZ; Schwartz LE; Cantrell LA; Stoler MH; Mills AM
Am J Surg Pathol; 2020 Jun; 44(6):782-792. PubMed ID: 31934920
[TBL] [Abstract][Full Text] [Related]
8. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D
Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547
[TBL] [Abstract][Full Text] [Related]
10. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
11. Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case.
Watanabe M; Shimizu K; Kato H; Imai H; Nakano H; Sugawa M; Shiraishi T
Gynecol Oncol; 2001 Sep; 82(3):563-7. PubMed ID: 11520156
[TBL] [Abstract][Full Text] [Related]
12. [Carcinosarcomas of the uterus: molecular-genetic and morphological features].
Levitskaia NV; Pozharisskiĭ KM; Vostriukhina OA; Alekseeva LN; Nemtsova MV; Matrosova IV; Kharitonova TV; Poddubnaia IV
Arkh Patol; 2012; 74(1):7-11. PubMed ID: 22712296
[TBL] [Abstract][Full Text] [Related]
13. Mismatch repair gene expression and genetic instability in testicular germ cell tumor.
Velasco A; Riquelme E; Schultz M; Wistuba II; Villarroel L; Pizarro J; Berlin A; Ittmann M; Koh MS; Leach FS
Cancer Biol Ther; 2004 Oct; 3(10):977-82. PubMed ID: 15467433
[TBL] [Abstract][Full Text] [Related]
14. Defective mismatch repair in the pathogenesis of low-grade appendiceal mucinous neoplasms and adenocarcinomas.
Misdraji J; Burgart LJ; Lauwers GY
Mod Pathol; 2004 Dec; 17(12):1447-54. PubMed ID: 15354187
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses.
Harms PW; Fullen DR; Patel RM; Chang D; Shalin SC; Ma L; Wood B; Beer TW; Siddiqui J; Carskadon S; Wang M; Palanisamy N; Fisher GJ; Andea A
Hum Pathol; 2015 May; 46(5):690-7. PubMed ID: 25704628
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Pal T; Sutphen R; Sellers T
Cancer; 2004 Jun; 100(11):2485-6; author reply 2486. PubMed ID: 15160358
[No Abstract] [Full Text] [Related]
18. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
Nunn J; Nagini S; Risk JM; Prime W; Maloney P; Liloglou T; Jones AS; Rogers SR; Gosney JR; Woolgar J; Field JK
Oral Oncol; 2003 Feb; 39(2):115-29. PubMed ID: 12509964
[TBL] [Abstract][Full Text] [Related]
19. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations.
Curia MC; Zuckermann M; De Lellis L; Catalano T; Lattanzio R; Aceto G; Veschi S; Cama A; Otte JB; Piantelli M; Mariani-Costantini R; Cetta F; Battista P
Mod Pathol; 2008 Jan; 21(1):7-14. PubMed ID: 17962810
[TBL] [Abstract][Full Text] [Related]
20. Mismatch repair, p53 and beta-catenin proteins in colorectal cancer.
Valentini AM; Renna L; Armentano R; Pirrelli M; Di Leo A; Gentile M; Caruso ML
Anticancer Res; 2002; 22(4):2083-8. PubMed ID: 12174887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
